Clinical Trial Design and Evidence Quality
How We Know What We Know
Why Trial Design Matters
Psychedelic studies are difficult because participants and researchers often know when a noticeable drug effect has occurred. That makes blinding difficult and can inflate expectations or bias.
Common Design Issues
Researchers must consider placebo effects, expectancy, sample size, follow-up length, therapist effects, and participant selection. Strong conclusions require careful controls and replication.
Evidence Quality Checklist
| Question | Why it matters |
|---|---|
| Was there a control group? | Helps separate drug effects from placebo or context effects |
| Was follow-up long enough? | Shows whether benefits last |
| Was the sample diverse? | Improves generalizability |
| Were adverse events measured? | Essential for safety |
Why is blinding difficult in psychedelic research?
Noticeable subjective effects can make it obvious whether someone received the active treatment.
Correct answer: The subjective effects can reveal who got the active drug
What is one factor that can bias psychedelic trial results because of expectations?
Expectancy can influence how participants rate outcomes.
Correct answer: expectancy
Reading Headlines Carefully
A positive trial is important, but it does not automatically mean a treatment is proven, available, or suitable for broad use.
Strong vs Weak Evidence
Stronger evidence
- Controlled comparison
- Replication across sites or studies
- Clear safety reporting
Weaker evidence
- Small uncontrolled samples
- Short follow-up
- Limited adverse-event data